
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year |
Award Type![]() |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Active |
2005 | R44 | CA101106 | RFA-CA-05-006 | RUSH, JOHN | CELL SIGNALING TECHNOLOGY, INC. | IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES | Complete |
2005 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
2008 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2006 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2016 | R43 | CA203671 | PAR-13-327 | OUELLETTE, STEVEN BRADLEY | KINASENSE, LLC | DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY | Complete |
2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
2002 | R43 | CA094404 | PAR-01-105 | MARTIN, MARK | MIRARI BIOSCIENCES, INC. | MICROWAVE-ENHANCED LUMINESCENCE TO DETECT GROWTH FACTORS | Complete |
2015 | R43 | CA199142 | PAR-13-327 | ORBAI, LUCIAN | CELL DATA SCIENCES, INC. | RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS | Complete |
1999 | R43 | CA081860 | PAR-98-066 | CHANG, HWAI W | STRATAGENE | GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES | Complete |
2001 | R43 | CA091423 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | SELECTION OF THE BEST LIGANDS FROM COMBINATORIAL LIBRARY | Complete |
2016 | R43 | CA203675 | PAR-13-327 | KLUGE, JONATHAN AUGUST | VAXESS TECHNOLOGIES, INC. | SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS | Complete |
2002 | R43 | CA096051 | PAR-01-105 | FENG, LI | ECHELON BIOSCIENCES, INC. | LIPID MICROARRAYS | Complete |
2015 | R43 | CA199152 | PAR-13-327 | EASTBURN, DENNIS J | MISSION BIO, INC. | MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING | Complete |
1999 | R43 | CA081870 | PAR-98-066 | MILLER, JEFFREY E. | IVS TECHNOLOGIES, LLC | NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS | Complete |
2001 | R43 | CA092796 | PAR-99-101 | SHEN, SHANXIANG | PROTIVERIS, INC. | MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING | Complete |
2016 | R43 | CA203629 | PAR-13-327 | GUNDERSON, KEVIN L | ENCODIA, INC. | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | Complete |
2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
2002 | R43 | CA096052 | PAR-01-105 | ISRAEL, BARBARA A. | PLATYPUS TECHNOLOGIES, LLC | OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS | Complete |
2015 | R43 | CA199211 | PAR-13-327 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE | Complete |
1999 | R43 | CA081890 | PAR-98-066 | NERI, BRUCE P | THIRD WAVE TECHNOLOGIES, INC. | SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION | Complete |
2001 | R43 | CA092819 | PAR-99-101 | WANG, PENCHENG | CALIBRANT BIOSYSTEMS, INC. | 2-D MICROFLUIDIC GENE SCANNER | Complete |
2004 | R43 | CA105536 | PAR-01-105 | BECKER, CHRISTOPHER H | SURROMED, INC. | DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME | Complete |
2016 | R43 | CA203647 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | Complete |
2002 | R43 | CA096053 | PAR-01-105 | BECKER, CHRISTOPHER | SURROMED, INC. | AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING | Complete |
1999 | R43 | CA081891 | PAR-98-066 | WEAVER, DANIEL C | GENOMICA CORPORATION | ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY | Complete |
2001 | R43 | CA092826 | PAR-99-101 | WANG, JIWU | ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS | INNOVATIVE RNA PROFILING IN CANCER CELLS | Complete |
2004 | R43 | CA105540 | PAR-01-105 | NIELSEN, ULRIK B. | MERRIMACK PHARMACEUTICALS, INC. | PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS | Complete |
2016 | R43 | CA203681 | PAR-13-327 | KING, JEFFREY S | VIROGENOMICS BIODEVELOPMENT, INC. | Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia | Complete |
2000 | R43 | CA081787 | PAR-99-101 | BUTT, TAUSEEF R. | LIFESENSORS, INC. | LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER | Complete |
2002 | R43 | CA096056 | PAR-01-105 | STRAUME, TORE | GENMETRIX, LLC | ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES | Complete |
1999 | R43 | CA081903 | PAR-98-066 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD | Complete |
2001 | R43 | CA093155 | PAR-99-101 | JOHNSON, PAUL H | EPIGENX PHARMACEUTICALS | WHOLE GENOME METHYLATION ASSAY | Complete |
2004 | R43 | CA105542 | PAR-01-105 | PARIS, MARK J | VACCINEX, INC. | FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS | Complete |
2000 | R43 | CA084678 | PAR-98-066 | BAMDAD, CYNTHIA C. | MINERVA BIOTECHNOLOGIES CORPORATION | RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS | Complete |
2002 | R43 | CA096059 | PAR-01-105 | LOGE, GARY | SPECTRUMEDIX CORPORATION | AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM | Complete |
1999 | R43 | CA081949 | PAR-98-066 | OLINER, JONATHAN D | AFFYMETRIX, INC. | REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS | Complete |
2001 | R43 | HL069675 | PAR-99-101 | WILLETT, CATHERINE E | PHYLONIX PHARMACEUTICALS, INC. | ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS | Complete |
2004 | R43 | CA107764 | PAR-01-105 | VYKOUKAL, JODY V | ADEPTAS, INC. | RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY | Complete |
2003 | R43 | CA099111 | PAR-01-105 | SHEN, LI | SUPERARRAY BIOSCIENCE CORPORATION | ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT | Complete |
2000 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
2002 | R43 | CA096065 | PAR-01-105 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | RAPID MOLECULAR DETECTION OF PML/RARALPHA | Complete |
1999 | R43 | CA081951 | PAR-98-066 | XANTHOPOULOS, KLEANTHIS G | AURORA BIOSCIENCES CORPORATION | ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS | Complete |
2001 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
2004 | R43 | CA108005 | PAR-01-105 | HEILIG, JOSEPH S | SOMALOGIC, INC. | APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT | Complete |
2003 | R43 | CA101271 | PAR-01-105 | DIATCHENKO, LUDA | ATTAGENE, INC. | PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER | Complete |
2009 | R43 | CA137737 | RFA-CA-08-011 | ZWICK, MICHAEL G | ANDROBIOSYS, INC. | PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU | Complete |